Exscientia’s $15M milestone from Sanofi; Lilly to take Gateway Labs to China

Plus, news about TenNor Therapeutics, Gan & Lee Pharmaceuticals, Orasis and Optus Pharmaceuticals:

Exscientia receives $15M milestone from Sanofi: The companies

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA grants orphan drug status to Ionis’ olezarsen for FCS

Share this article Olezarsen is currently undergoing evaluation for individuals at risk of diseases caused by elevated triglyceride levels, including FCS. Credit: metamorworks / Shutterstock.com.

February 16, 2024

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 4, 2024

High-Sensitivity Troponin Test May Overestimate Risk in PE

For patients with hemodynamically stable pulmonary embolism (PE), there was no prognostic value found for the mild elevations in cardiac troponin captured only on high-sensitivity

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.